Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 1056-1060

  Zhong, Lilin ^a   Haynes, Lia ^b   Struble, Evi Budo ^a   Tamin, Azaibi ^b   Virata Theimer, Maria Luisa ^a   Zhang, Pei ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Epitope; Monoclonal antibody; Neutralization; SARS CoV

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN VP4;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SARS CORONAVIRUS; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS INTERFERENCE; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPE MAPPING; EPITOPES; HUMANS; MEMBRANE GLYCOPROTEINS; NEUTRALIZATION TESTS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS;

SARS CORONAVIRUS;

EID: 70449697853     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.115     Document Type: Article

References (32)

1. Holmes K.V. SARS-associated coronavirus. N. Engl. J. Med. 348 (2003) 1948-1951
2. Liu W., Fontanet A., Zhang P.H., Zhan L., Xin Z.T., Baril L., Tang F., Lv H., and Cao W.C. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J. Infect. Dis. 193 (2006) 792-795
3. Nie Y., Wang G., Shi X., Zhang H., Qiu Y., He Z., Wang W., Lian G., Yin X., Du L., Ren L., Wang J., He X., Li T., Deng H., and Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190 (2004) 1119-1126
4. Yang Z.Y., Werner H.C., Kong W.P., Leung K., Traggiai E., Lanzavecchia A., and Nabel G.J. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc. Natl. Acad. Sci. USA 102 (2005) 797-801
5. Zhang J.S., Chen J.T., Liu Y.X., Zhang Z.S., Gao H., Liu Y., Wang X., Ning Y., Liu Y.F., Gao Q., Xu J.G., Qin C., Dong X.P., and Yin W.D. A serological survey on neutralizing antibody titer of SARS convalescent sera. J. Med. Virol. 77 (2005) 147-150
6. Bartosch B., Bukh J., Meunier J.C., Granier C., Engle R.E., Blackwelder W.C., Emerson S.U., Cosset F.L., and Purcell R.H. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. USA 100 (2003) 14199-14204
7. Burton D.R., Stanfield R.L., and Wilson I.A. Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA 102 (2005) 14943-14948
8. Logvinoff C., Major M.E., Oldach D., Heyward S., Talal A., Balfe P., Feinstone S.M., Alter H., Rice C.M., and McKeating J.A. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 101 (2004) 10149-10154
9. Zhang P., Wu C.G., Mihalik K., Virata-Theimer M.L., Yu M.Y., Alter H.J., and Feinstone S.M. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc. Natl. Acad. Sci. USA 104 (2007) 8449-8454
10. Zhou T., Xu L., Dey B., Hessell A.J., Van Ryk D., Xiang S.H., Yang X., Zhang M.Y., Zwick M.B., Arthos J., Burton D.R., Dimitrov D.S., Sodroski J., Wyatt R., Nabel G.J., and Kwong P.D. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445 (2007) 732-737
11. Dulbecco R., Vogt M., and Strickland A.G. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2 (1956) 162-205
12. Massey R.J., and Schochetman G. Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science 213 (1981) 447-449
13. Zhang P., Zhong L., Struble E.B., Watanabe H., Kachko A., Mihalik K., Virata-Theimer M.L., Alter H.J., Feinstone S., and Major M. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc. Natl. Acad. Sci. USA 106 (2009) 7537-7541
14. Tripp R.A., Haynes L.M., Moore D., Anderson B., Tamin A., Harcourt B.H., Jones L.P., Yilla M., Babcock G.J., Greenough T., Ambrosino D.M., Alvarez R., Callaway J., Cavitt S., Kamrud K., Alterson H., Smith J., Harcourt J.L., Miao C., Razdan R., Comer J.A., Rollin P.E., Ksiazek T.G., Sanchez A., Rota P.A., Bellini W.J., and Anderson L.J. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J. Virol. Methods 128 (2005) 1-28
15. Kiley M.P., Regnery R.L., and Johnson K.M. Ebola virus: identification of virion structural proteins. J. Gen. Virol. 49 (1980) 333-341
16. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., and Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc. Natl. Acad. Sci. USA 101 (2004) 2536-2541
17. Barany G., and Merrifield R.B. The peptides, analysis, synthesis, biology. In: Gross E., and Meienhofer J. (Eds). The Peptides (1980), Academic Press, New York 1-284
18. Zhang P., Yu M.Y., Venable R., Alter H.J., and Shih J.W. Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. Proc. Natl. Acad. Sci. USA 103 (2006) 9214-9219
19. Prabakaran P., Gan J., Feng Y., Zhu Z., Choudhry V., Xiao X., Ji X., and Dimitrov D.S. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J. Biol. Chem. 281 (2006) 15829-15836
20. Hwang W.C., Lin Y., Santelli E., Sui J., Jaroszewski L., Stec B., Farzan M., Marasco W.A., and Liddington R.C. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J. Biol. Chem. 281 (2006) 34610-34616
21. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 (2005) 1864-1868
22. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The protein data bank. Nucleic Acids Res. 28 (2000) 235-242
23. W.L. DeLano, The PyMOL Molecular Graphics System, (2002). Available from: .
24. Davies D.R., and Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. USA 93 (1996) 7-12
25. Klasse P.J., and Moore J.P. Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1. J. Virol. 70 (1996) 3668-3677
26. Klasse P.J., and Sattentau Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83 (2002) 2091-2108
27. Sullivan N.J. Antibody-mediated enhancement of viral disease. Curr. Top. Microbiol. Immunol. 260 (2001) 145-169
28. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
29. Fleury D., Barrère B., Bizebard T., Daniels R.S., Skehel J.J., and Knossow M. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6 (1999) 530-534
30. Jeffers S.A., Tusell S.M., Gillim-Ross L., Hemmila E.M., Achenbach J.E., Babcock G.J., Thomas Jr. W.D., Thackray L.B., Young M.D., Mason R.J., Ambrosino D.M., Wentworth D.E., Demartini J.C., and Holmes K.V. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 101 (2004) 15748-15753
31. Shih Y.P., Chen C.Y., Liu S.J., Chen K.H., Lee Y.M., Chao Y.C., and Chen Y.M. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J. Virol. 80 (2006) 10315-10324
32. Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., and Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78 (2004) 5642-5650